Benitec Biopharma (BNTC) Cash from Investing Activities (2019 - 2025)
Benitec Biopharma (BNTC) reported Cash from Investing Activities of -$11000.0 for Q4 2025, up 38.89% sequentially from -$18000.0 in Q2 2025.
Benitec Biopharma (BNTC) Cash from Investing Activities (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 6 years of Cash from Investing Activities data on file, last reported at -$11000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$11000.0; the trailing twelve-month figure through Dec 2025 stood at -$29000.0 (up 83.8% YoY), and the FY2025 full-year result was -$18000.0, up 89.94% from the prior year.
- Cash from Investing Activities climbed to -$11000.0 in Q4 2025, from -$18000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $141000.0 in Q2 2021 to a low of -$179000.0 in Q1 2024.
- A 4-year average of -$15833.3 and a median of -$14000.0 in 2021 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities surged 1184.62% in 2021 and slumped 109.22% in 2022, its largest moves.
- Tracing BNTC's Cash from Investing Activities over 4 years: stood at $141000.0 in 2021, then tumbled by 109.22% to -$13000.0 in 2022, then tumbled by 1276.92% to -$179000.0 in 2024, then soared by 93.85% to -$11000.0 in 2025.
- Business Quant data shows BNTC's Cash from Investing Activities at -$11000.0 in Q4 2025, -$18000.0 in Q2 2025, and -$179000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -45.51 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 178,242.27 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 172.62 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2024 | -179,000.00 |
| Mar 31, 2024 | -179,000.00 |
| Jun 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -13,000.00 |
| Jun 30, 2021 | 141,000.00 |
| Jun 30, 2021 | 141,000.00 |
| Mar 31, 2021 | -15,000.00 |
| Mar 31, 2021 | -15,000.00 |
| Dec 31, 2020 | -174,000.00 |
| Dec 31, 2020 | -174,000.00 |
| Sep 30, 2020 | -173,000.00 |
| Sep 30, 2020 | -173,000.00 |
| Jun 30, 2020 | -13,000.00 |
| Jun 30, 2020 | -13,000.00 |
| Dec 31, 2019 | -82,000.00 |
| Dec 31, 2019 | -82,000.00 |